<div class="embed-responsive embed-responsive-16by9"><iframe width="640" height="360" style="max-width: 100%;max-height: 100%; border:none;" src="https://alive528.com/videoEmbed/18170/%D7%93-%D7%A8-%D7%9E%D7%A1%D7%90%D7%A0%D7%95%D7%A8%D7%99-%D7%A4%D7%95%D7%A7%D7%95%D7%A9%D7%99%D7%9E%D7%94-%D7%AA%D7%95%D7%A7%D7%A3-%D7%90%D7%AA-%D7%9E%D7%A9%D7%A8%D7%93-%D7%94%D7%91%D7%A8%D7%99%D7%90%D7%95%D7%AA-%D7%91%D7%99%D7%A4%D7%9F-%D7%A2%D7%9C%D7%99%D7%9B%D7%9D-%D7%9C%D7%97%D7%A7%D7%95%D7%A8-%D7%95%D7%9C%D7%91%D7%93%D7%95%D7%A7-%D7%90%D7%AA-%D7%AA%D7%95%D7%A4%D7%A2%D7%95%D7%AA-%D7%94%D7%9C%D7%95%D7%95%D7%90%D7%99-%D7%A9%D7%9C-%D7%96%D7%A8%D7%99%D7%A7%D7%95%D7%AA-%D7%94%D7%A7%D7%95%D7%A8%D7%95%D7%A0%D7%94" frameborder="0" allowfullscreen="allowfullscreen" allow="autoplay" scrolling="no">iFrame is not supported!</iframe></div>

ד''ר מסאנורי פוקושימה תוקף את משרד הבריאות ביפן: עליכם לחקור ולבדוק את תופעות הלוואי של זריקות הקורונה

0:02:24

newsfromaroundtheworld

2 साल 44 चेतावनी

Share Please login to donate MP3 Add to Report 0

Permanent Link

URL Friendly (SEO)

Current Time (SEO)

वर्ग:

News

{imgURL}
{title}
{channelName}

{category_name}

Open toolbar

Increase Text Decrease Text Grayscale High Contrast Negative Contrast Links Underline Readable Font Reset

Verify Email Address

Enter Code (Code will expire in 05:00) * Code will only last 5 minutes

02:00 to resend

Your index is currently INACTIVE.

Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.

Terms and Conditions

already exist

Enter new Engine Name

ד''ר מסאנורי פוקושימה תוקף את משרד הבריאות ביפן: עליכם לחקור ולבדוק את תופעות הלוואי של זריקות הקורונה

Embed Options

Verify Email Address

02:00 to resend

Your index is currently INACTIVE. Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.

Terms and Conditions

Your index is currently INACTIVE.

Please check your platform contents to make sure it doesn't violate the terms and condition before indexing.